#China #Riyadh #Aphranel #CaHA Filler #MagiCConcept

Aphranel's Prominent Debut at SAAM 2025

Aphranel, an aesthetic brand hailing from China via SHANGHAI MOYANG BIOTECHNOLOGY, marked its debut at the 4th Saudi Arabia Aesthetic Medicine Scientific Congress (SAAM 2025) in Riyadh, where it captivated attendees with the introduction of its MagiCCrystal calcium hydroxyapatite (CaHA) filler. This product presentation highlighted the brand's commitment to integrating innovative technologies and techniques into the aesthetic medicine sphere, showcasing its capabilities both regionally and globally.

The event attracted over 2,500 participants, including professionals from the United States, Germany, Switzerland, and the broader Middle East. This gathering is recognized as one of the region's most influential meetings for aesthetic medicine, emphasizing areas such as aesthetic dermatology, laser therapies, plastic surgery, and broader medical aesthetics.

Aphranel's participation was further marked by its collaboration with renowned Chinese clinicians such as Dr. Wang Wenting from Guangzhou Yestar and Dr. Chen Lorraine from Shanghai LELITE M. Their joint presentations provided practical demonstrations of the advancements in injection protocols and regenerative materials that the brand aims to promote in the growing global market.

The company's spotlight on the MagiCCrystal filler was grounded in proprietary technologies that form the backbone of its formulation. Notably, Aphranel presented:

• - ACD-MT Technology: Characterized by the innovative 'raspberry-like' through-pore microsphere design, which enhances the filler’s effectiveness and performance.
• - PCD-ETT Technology: A physical cross-linking gel method that ensures both immediate and long-term results in collagen regeneration while guaranteeing a safe degradation profile.

A live demonstration by Dr. Wang showcased meticulous techniques in injection layer selection and dosage control, while Dr. Chen articulated a structured approach titled,